Published on 30 May 2024 on Investing.com
AstraZeneca shares target raised by Argus on new drug approvals By Investing.com
On Thursday, AstraZeneca PLC (NASDAQ:LON:AZN) shares received an updated price target from a market...
NASDAQ.AZN price evolution
Want to become a better investor?
Start tracking your investments with Statfolio
Sign up for free